These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 28406710)
1. Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions. Loh CH; Peters SP; Lovings TM; Ohar JA Ann Am Thorac Soc; 2017 Aug; 14(8):1305-1311. PubMed ID: 28406710 [TBL] [Abstract][Full Text] [Related]
2. Suboptimal Peak Inspiratory Flow in Patients Hospitalized for COPD Exacerbation: Prevalence and Predictive Factors. González-Montaos A; Pazos-Area L; Represas-Represas C; Ramos-Hernández C; Lojo-Rodríguez I; Priegue-Carrera A; Aballe-Santos L; Fernández-Villar A J Aerosol Med Pulm Drug Deliv; 2024 Oct; 37(5):225-231. PubMed ID: 39388689 [No Abstract] [Full Text] [Related]
3. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission. Bartels W; Adamson S; Leung L; Sin DD; van Eeden SF Int J Chron Obstruct Pulmon Dis; 2018; 13():1647-1654. PubMed ID: 29872284 [TBL] [Abstract][Full Text] [Related]
4. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations]. Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981 [TBL] [Abstract][Full Text] [Related]
5. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters. Malmberg LP; Rytilä P; Happonen P; Haahtela T Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():257-62. PubMed ID: 20714380 [TBL] [Abstract][Full Text] [Related]
6. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate. Mahler DA; Waterman LA; Ward J; Gifford AH J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526 [TBL] [Abstract][Full Text] [Related]
7. Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study. Clark B; Wells BJ; Saha AK; Franchino-Elder J; Shaikh A; Donato BMK; Ohar JA Int J Chron Obstruct Pulmon Dis; 2022; 17():1483-1494. PubMed ID: 35791340 [TBL] [Abstract][Full Text] [Related]
8. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020 [TBL] [Abstract][Full Text] [Related]
9. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation. Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952 [TBL] [Abstract][Full Text] [Related]
10. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Keshishian A; Xie L; Dembek C; Yuce H Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815 [TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation. Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098 [No Abstract] [Full Text] [Related]
12. Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD. Adamson SL; Burns J; Camp PG; Sin DD; van Eeden SF Int J Chron Obstruct Pulmon Dis; 2016; 11():61-71. PubMed ID: 26792986 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler. Mahler DA; Waterman LA; Gifford AH J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):174-9. PubMed ID: 23025451 [TBL] [Abstract][Full Text] [Related]
14. Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow. Ohar JA; Mahler DA; Davis GN; Lombardi DA; Moran EJ; Crater GD Can Respir J; 2024; 2024():8034923. PubMed ID: 38560416 [TBL] [Abstract][Full Text] [Related]
15. The Repeatability of Inspiration Performance Through Different Inhalers in Patients with Chronic Obstructive Pulmonary Disease and Control Volunteers. Erdelyi T; Lazar Z; Odler B; Tamasi L; Müller V J Aerosol Med Pulm Drug Deliv; 2020 Oct; 33(5):271-281. PubMed ID: 32460588 [No Abstract] [Full Text] [Related]
16. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948 [TBL] [Abstract][Full Text] [Related]
17. Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease. Pleasants RA; Shaikh A; Henderson AG; Bayer V; Drummond MB J Aerosol Med Pulm Drug Deliv; 2024 Aug; 37(4):171-179. PubMed ID: 38814000 [No Abstract] [Full Text] [Related]
18. Inspiratory muscle training may increase peak inspiratory flow in chronic obstructive pulmonary disease. Weiner P; Weiner M Respiration; 2006; 73(2):151-6. PubMed ID: 16155355 [TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study. Mahler DA; Demirel S; Hollander R; Gopalan G; Shaikh A; Mahle CD; Elder J; Morrison C Chronic Obstr Pulm Dis; 2022 Jul; 9(3):427-438. PubMed ID: 35788259 [TBL] [Abstract][Full Text] [Related]
20. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial. Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]